NO924321L - Synergistiske terapeutiske blandinger og fremgangsmaater - Google Patents

Synergistiske terapeutiske blandinger og fremgangsmaater

Info

Publication number: NO924321L
Authority: NO; Norway
Prior art keywords: mammal; synergistic; angiotensin; blood pressure; heart failure
Prior art date: 1990-05-11

Application number

NO92924321A

Other languages

English (en)

Norwegian (no)

Other versions

NO924321D0 (no

Inventor

Anthony Andrea Fossa

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-05-11

Filing date

1992-11-10

Publication date

1993-01-08

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24080550&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO924321(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1992-11-10 Application filed by Pfizer filed Critical Pfizer

1992-11-10 Publication of NO924321D0 publication Critical patent/NO924321D0/no

1993-01-08 Publication of NO924321L publication Critical patent/NO924321L/no

Links

230000002195 synergetic effect Effects 0.000 title abstract 5
230000001225 therapeutic effect Effects 0.000 title abstract 5
238000000034 method Methods 0.000 title abstract 4
239000000203 mixture Substances 0.000 title abstract 3
241000124008 Mammalia Species 0.000 abstract 4
206010019280 Heart failures Diseases 0.000 abstract 3
230000036772 blood pressure Effects 0.000 abstract 3
229940123413 Angiotensin II antagonist Drugs 0.000 abstract 2
239000002333 angiotensin II receptor antagonist Substances 0.000 abstract 2
238000006243 chemical reaction Methods 0.000 abstract 2
239000003814 drug Substances 0.000 abstract 2
239000002532 enzyme inhibitor Substances 0.000 abstract 2
229940125532 enzyme inhibitor Drugs 0.000 abstract 2
239000002461 renin inhibitor Substances 0.000 abstract 2
229940086526 renin-inhibitors Drugs 0.000 abstract 2
235000013547 stew Nutrition 0.000 abstract 2
229940124597 therapeutic agent Drugs 0.000 abstract 2
101800000734 Angiotensin-1 Proteins 0.000 abstract 1
102400000344 Angiotensin-1 Human genes 0.000 abstract 1
206010007559 Cardiac failure congestive Diseases 0.000 abstract 1
ORWYRWWVDCYOMK-HBZPZAIKSA-N angiotensin I Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C1=CC=C(O)C=C1 ORWYRWWVDCYOMK-HBZPZAIKSA-N 0.000 abstract 1
239000005557 antagonist Substances 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
239000003112 inhibitor Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Cardiology (AREA)
Organic Chemistry (AREA)
Heart & Thoracic Surgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Plant Substances (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO92924321A 1990-05-11 1992-11-10 Synergistiske terapeutiske blandinger og fremgangsmaater NO924321L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US52236090A	1990-05-11	1990-05-11
PCT/US1991/002733 WO1991017771A1 (en)	1990-05-11	1991-04-22	Synergistic therapeutic compositions and methods

Publications (2)

Publication Number	Publication Date
NO924321D0 NO924321D0 (no)	1992-11-10
NO924321L true NO924321L (no)	1993-01-08

Family

ID=24080550

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO92924321A NO924321L (no)	1990-05-11	1992-11-10	Synergistiske terapeutiske blandinger og fremgangsmaater

Country Status (33)

Country	Link
US (2)	US6716875B1 (ja)
EP (1)	EP0527879B1 (ja)
JP (2)	JPH0729938B2 (ja)
KR (1)	KR970005839B1 (ja)
CN (7)	CN1879884A (ja)
AP (1)	AP240A (ja)
AT (1)	ATE148632T1 (ja)
AU (1)	AU653724B2 (ja)
BG (1)	BG61831B1 (ja)
BR (1)	BR9106438A (ja)
CA (1)	CA2081564C (ja)
DE (1)	DE69124598T2 (ja)
DK (1)	DK0527879T3 (ja)
EG (1)	EG19648A (ja)
ES (1)	ES2097208T3 (ja)
GR (1)	GR3022997T3 (ja)
GT (1)	GT199100032A (ja)
HU (1)	HU227346B1 (ja)
IE (1)	IE911592A1 (ja)
IL (1)	IL98055A (ja)
IS (1)	IS2042B (ja)
MA (1)	MA22150A1 (ja)
MY (1)	MY114347A (ja)
NO (1)	NO924321L (ja)
NZ (1)	NZ238118A (ja)
PE (1)	PE30891A1 (ja)
PT (1)	PT97615B (ja)
RO (1)	RO115786B1 (ja)
RU (1)	RU2147875C1 (ja)
TW (1)	TW203553B (ja)
WO (1)	WO1991017771A1 (ja)
YU (1)	YU49094B (ja)
ZA (1)	ZA913539B (ja)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2097208T3 (es) *	1990-05-11	1997-04-01	Pfizer	Composiciones y procedimientos terapeuticos y sinergicos.
EP0629408A1 (en) *	1993-06-16	1994-12-21	LABORATOIRES MERCK, SHARP & DOHME-CHIBRET	Combination of angiotensin converting enzyme inhibitors and AII antagonists
DE4340437C1 (de) *	1993-11-27	1995-05-24	Karla Dr Lehmann	Verwendung von Lithiumverbindungen zur Behandlung von Herzinsuffizienz einschließlich ihrer Folgeerkrankungen
KR19980703647A (ko) *	1995-04-07	1998-12-05	베르너발데크	베나제프릴 또는 베나제프릴라트 및 발사르탄을 함유하는조성물
JPH11508894A (ja) *	1995-06-30	1999-08-03	メルクエンドカンパニーインコーポレーテッド	Ａｃｅ阻害剤とａｉｉ拮抗薬を用いる腎疾患の治療方法
NZ330774A (en) *	1996-04-05	1999-06-29	Takeda Chemical Industries Ltd	Pharmaceutical composition having angiotensin ii antagonistic activity or salt thereof with an insulin-sensitivity increasing compound and postprandial hyperglycemia in diabetes mellitus and antagonistic activity and increased insulin-sensitivity
CA2257946A1 (en) *	1996-06-24	1997-12-31	Merck & Co., Inc.	A composition of enalapril and losartan
US6087386A (en) *	1996-06-24	2000-07-11	Merck & Co., Inc.	Composition of enalapril and losartan
AU9509798A (en) *	1997-09-25	1999-04-12	University Of Florida	Antisense oligonucleotide compositions targeted to angiotensi n converting enzy me mrna and methods of use
BR9814422A (pt) *	1997-12-23	2000-10-10	Warner Lambert Co	Combinações de inibidor de ace - inibidor de mmp
US6087343A (en) *	1998-09-14	2000-07-11	University Of Florida	Antisense oligonucleotides targeted to β-1 adrenoceptor and methods of use
US6387894B1 (en) *	1999-06-11	2002-05-14	Pfizer Inc.	Use of CRF antagonists and renin-angiotensin system inhibitors
US8168616B1 (en) *	2000-11-17	2012-05-01	Novartis Ag	Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
AU2003250858A1 (en) *	2002-06-28	2004-01-19	Novartis Ag	Use of organic compounds
PL2368554T3 (pl)	2003-04-08	2015-05-29	Progenics Pharm Inc	Preparaty farmaceutyczne zawierające metylonaltrekson
US20040265238A1 (en)	2003-06-27	2004-12-30	Imtiaz Chaudry	Inhalable formulations for treating pulmonary hypertension and methods of using same
RU2407523C2 (ru) *	2004-10-08	2010-12-27	Новартис Аг	Применение ингибиторов ренина для профилактики или лечения диастолической дисфункции или диастолической сердечной недостаточности
MX2007010833A (es) *	2005-03-07	2009-02-17	Univ Chicago	Uso de antagonistas opioides para atenuar proliferacion y migracion de células endoteliales.
US8518962B2 (en)	2005-03-07	2013-08-27	The University Of Chicago	Use of opioid antagonists
US9662325B2 (en)	2005-03-07	2017-05-30	The University Of Chicago	Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US8524731B2 (en)	2005-03-07	2013-09-03	The University Of Chicago	Use of opioid antagonists to attenuate endothelial cell proliferation and migration
AR057325A1 (es)	2005-05-25	2007-11-28	Progenics Pharm Inc	Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos
AR057035A1 (es)	2005-05-25	2007-11-14	Progenics Pharm Inc	SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS
TWI489984B (zh)	2006-08-04	2015-07-01	Wyeth Corp	用於非經腸道傳輸化合物之配方及其用途
TW200817048A (en) *	2006-09-08	2008-04-16	Wyeth Corp	Dry powder compound formulations and uses thereof
CL2007002689A1 (es)	2006-09-18	2008-04-18	Vitae Pharmaceuticals Inc	Compuestos derivados de piperidin-1-carboxamida, inhibidores de la renina; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como hipertension, insuficiencia cardiaca, fibrosis cardiaca, entre otras.
MX2009010550A (es)	2007-03-29	2009-12-14	Progenics Pharm Inc	Formas de cristal de bromuro de (r)-n-metilnaltrexona y uso de las mismas.
JP5469593B2 (ja)	2007-03-29	2014-04-16	ワイス・エルエルシー	末梢性オピオイド受容体アンタゴニストおよびその使用
WO2008121348A2 (en)	2007-03-29	2008-10-09	Progenics Pharmaceuticals, Inc.	Peripheral opioid receptor antagonists and uses thereof
AU2008349873B2 (en)	2008-02-06	2014-02-13	Progenics Pharmaceuticals, Inc.	Preparation and use of (R),(R)-2,2'-bis-methylnaltrexone
CA2719134C (en)	2008-03-21	2015-06-30	The University Of Chicago	Treatment with opioid antagonists and mtor inhibitors
CA2676881C (en)	2008-09-30	2017-04-25	Wyeth	Peripheral opioid receptor antagonists and uses thereof
AR077692A1 (es)	2009-08-06	2011-09-14	Vitae Pharmaceuticals Inc	Sales de 2-((r)-(3-clorofenil) ((r)-1-((s) -2-(metilamino)-3-((r)-tetrahidro-2h-piran-3-il) propilcarbamoil) piperidin -3-il) metoxi) etilcarbamato de metilo
CN102423483A (zh) *	2011-11-24	2012-04-25	西北农林科技大学	一种复方雷米普利纳米乳抗高血压药物
CN114032273B (zh) *	2021-11-17	2024-02-02	山东省科学院生物研究所	一种多功能西洋参水解肽及其制备方法和应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US324377A (en) *		1885-08-18		Roller-skate
US4046889A (en) *	1976-02-13	1977-09-06	E. R. Squibb & Sons, Inc.	Azetidine-2-carboxylic acid derivatives
IL58849A (en) *	1978-12-11	1983-03-31	Merck & Co Inc	Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
JPS5671074A (en) *	1979-11-12	1981-06-13	Takeda Chem Ind Ltd	1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative
US4749688A (en)	1986-06-20	1988-06-07	Schering Corporation	Use of neutral metalloendopeptidase inhibitors in the treatment of hypertension
CA1334092C (en)	1986-07-11	1995-01-24	David John Carini	Angiotensin ii receptor blocking imidazoles
DE3633861A1 (de) *	1986-10-04	1988-04-07	Thomae Gmbh Dr K	Neue imidazo-benzoxazinone, ihre herstellung und diese verbindungen enthaltende arzneimittel
US4814342A (en)	1986-10-31	1989-03-21	Pfizer Inc.	Nor-statine and nor-cyclostatine polypeptides
US4895834A (en) *	1986-12-15	1990-01-23	Warner-Lambert Company	Renin inhibitors III
WO1988005432A1 (fr) *	1987-01-23	1988-07-28	Yoshitomi Pharmaceutical Industries, Ltd.	Compose de 5-hydroxyindole-3-carboxamide et son usage en medecine
US4962105A (en)	1987-10-19	1990-10-09	Ciba-Geigy Corporation	Potentiation of antihypertensive effect of ace inhibitors
US5015651A (en)	1988-01-07	1991-05-14	E. I. Du Pont De Nemours And Company	Treatment of hypertension with 1,2,4-angiotensin II antagonists
US4880804A (en) *	1988-01-07	1989-11-14	E. I. Du Pont De Nemours And Company	Angiotensin II receptor blocking benzimidazoles
CA1338238C (en)	1988-01-07	1996-04-09	David John Carini	Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
IL91780A (en)	1988-10-04	1995-08-31	Abbott Lab	History of the amine of the xenon-preventing xanine acid, the process for their preparation and the pharmaceutical preparations containing them
ES2097208T3 (es) *	1990-05-11	1997-04-01	Pfizer	Composiciones y procedimientos terapeuticos y sinergicos.

1991
- 1991-04-22 ES ES91909382T patent/ES2097208T3/es not_active Expired - Lifetime
- 1991-04-22 AU AU78591/91A patent/AU653724B2/en not_active Expired
- 1991-04-22 AT AT91909382T patent/ATE148632T1/de not_active IP Right Cessation
- 1991-04-22 DE DE69124598T patent/DE69124598T2/de not_active Expired - Lifetime
- 1991-04-22 HU HU9203522A patent/HU227346B1/hu unknown
- 1991-04-22 CA CA002081564A patent/CA2081564C/en not_active Expired - Lifetime
- 1991-04-22 BR BR919106438A patent/BR9106438A/pt not_active Application Discontinuation
- 1991-04-22 EP EP91909382A patent/EP0527879B1/en not_active Expired - Lifetime
- 1991-04-22 WO PCT/US1991/002733 patent/WO1991017771A1/en not_active Ceased
- 1991-04-22 RO RO92-01405A patent/RO115786B1/ro unknown
- 1991-04-22 RU RU92016534A patent/RU2147875C1/ru active
- 1991-04-22 KR KR1019920702805A patent/KR970005839B1/ko not_active Expired - Lifetime
- 1991-04-22 DK DK91909382.3T patent/DK0527879T3/da active
- 1991-04-22 JP JP3508991A patent/JPH0729938B2/ja not_active Expired - Lifetime
- 1991-05-01 TW TW080103439A patent/TW203553B/zh not_active IP Right Cessation
- 1991-05-03 IL IL9805591A patent/IL98055A/en not_active IP Right Cessation
- 1991-05-06 AP APAP/P/1991/000258A patent/AP240A/en active
- 1991-05-08 EG EG27891A patent/EG19648A/xx active
- 1991-05-08 MA MA22420A patent/MA22150A1/fr unknown
- 1991-05-09 PT PT97615A patent/PT97615B/pt not_active IP Right Cessation
- 1991-05-10 IE IE159291A patent/IE911592A1/en not_active IP Right Cessation
- 1991-05-10 CN CNA2006100934632A patent/CN1879884A/zh active Pending
- 1991-05-10 MY MYPI91000798A patent/MY114347A/en unknown
- 1991-05-10 NZ NZ238118A patent/NZ238118A/en unknown
- 1991-05-10 IS IS3703A patent/IS2042B/is unknown
- 1991-05-10 CN CN91103177A patent/CN1065140C/zh not_active Expired - Lifetime
- 1991-05-10 CN CN2005100035730A patent/CN1824315B/zh not_active Expired - Lifetime
- 1991-05-10 GT GT199100032A patent/GT199100032A/es unknown
- 1991-05-10 CN CNA2007101867127A patent/CN101156949A/zh active Pending
- 1991-05-10 ZA ZA913539A patent/ZA913539B/xx unknown
- 1991-05-10 CN CNA2006101018493A patent/CN1915428A/zh active Pending
- 1991-05-10 PE PE1991185538A patent/PE30891A1/es unknown
- 1991-05-10 YU YU81991A patent/YU49094B/sh unknown
- 1991-05-10 CN CNB2003101199156A patent/CN100358578C/zh not_active Expired - Lifetime
1992
- 1992-11-10 NO NO92924321A patent/NO924321L/no unknown
- 1992-11-10 BG BG97068A patent/BG61831B1/bg unknown
1994
- 1994-06-27 JP JP6144998A patent/JP2635291B2/ja not_active Expired - Lifetime
1995
- 1995-06-05 US US08/465,660 patent/US6716875B1/en not_active Expired - Lifetime
- 1995-06-05 US US08/463,878 patent/US6900234B1/en not_active Expired - Lifetime
1997
- 1997-04-01 GR GR970400671T patent/GR3022997T3/el unknown
2000
- 2000-04-29 CN CN00108186A patent/CN1307901A/zh active Pending

Also Published As

Publication number	Publication date
CN101156949A (zh)	2008-04-09
RU2147875C1 (ru)	2000-04-27
AP240A (en)	1993-02-18
CN100358578C (zh)	2008-01-02
HUT62804A (en)	1993-06-28
MA22150A1 (fr)	1991-12-31
BR9106438A (pt)	1993-05-18
CN1307901A (zh)	2001-08-15
EP0527879B1 (en)	1997-02-05
GT199100032A (es)	1992-10-31
CN1915428A (zh)	2007-02-21
HU227346B1 (en)	2011-04-28
HK1094148A1 (en)	2007-03-23
US6900234B1 (en)	2005-05-31
CN1824315B (zh)	2011-01-12
AU7859191A (en)	1991-12-10
PT97615A (pt)	1992-03-31
CN1056426A (zh)	1991-11-27
BG61831B1 (bg)	1998-07-31
CN1502370A (zh)	2004-06-09
EG19648A (en)	1995-09-30
NO924321D0 (no)	1992-11-10
JPH0729938B2 (ja)	1995-04-05
CN1065140C (zh)	2001-05-02
RO115786B1 (ro)	2000-06-30
DK0527879T3 (da)	1997-07-14
CA2081564A1 (en)	1991-11-12
WO1991017771A1 (en)	1991-11-28
NZ238118A (en)	1997-06-24
DE69124598D1 (de)	1997-03-20
YU49094B (sh)	2003-12-31
EP0527879A1 (en)	1993-02-24
ES2097208T3 (es)	1997-04-01
JPH0748280A (ja)	1995-02-21
HU9203522D0 (en)	1993-01-28
TW203553B (ja)	1993-04-11
US6716875B1 (en)	2004-04-06
JPH05505618A (ja)	1993-08-19
YU81991A (sh)	1994-06-24
CN1879884A (zh)	2006-12-20
IS3703A7 (is)	1991-11-12
MY114347A (en)	2002-10-31
GR3022997T3 (en)	1997-07-30
IE911592A1 (en)	1991-11-20
PE30891A1 (es)	1991-11-27
IL98055A0 (en)	1992-06-21
JP2635291B2 (ja)	1997-07-30
AP9100258A0 (en)	1991-07-31
ATE148632T1 (de)	1997-02-15
BG97068A (bg)	1993-12-24
PT97615B (pt)	1998-08-31
AU653724B2 (en)	1994-10-13
KR970005839B1 (ko)	1997-04-21
ZA913539B (en)	1992-12-30
DE69124598T2 (de)	1997-05-28
IL98055A (en)	1996-10-31
IS2042B (is)	2005-09-15
CA2081564C (en)	1998-02-03
CN1824315A (zh)	2006-08-30

Publication	Publication Date	Title
MY114347A (en)	2002-10-31	Synergistic therapeutic compositions and methods.
RU92016534A (ru)	1995-06-19	Синергетические терапевтические композиции и способы достижения синергетического терапевтического эффекта
NO923130L (no)	1993-02-15	Behandling av kongestiv hjertesvikt
Edwards et al.	1985	Angiotensin-converting enzyme inhibitors: past, present, and bright future
Brown et al.	1998	Angiotensin-converting enzyme inhibitors
NO20055863L (no)	2001-09-12	W-karboksyarylsubstituerte difenylureaforbindelser som raf-kinaseinhibitorer
NO920298L (no)	1992-07-31	2,3,6-substituerte kinazolinoner
WO2003057225A3 (en)	2004-04-08	Phosphate transport inhibitors
NO20056252L (no)	2005-12-30	Terapeutiske og profylaktiske metoder for neuromuskulaere lidelser
NO950774L (no)	1995-09-04	Fremgangsmåte for inhibering av bentap og nedsettelse av serumkolesterol
PL308217A1 (en)	1995-07-24	Derivatives of 1-(oxo-acetyl)-piperidine-2-carboxylic as agents sensibilising multiple-drug-resistant cancer cells
AU3664401A (en)	2001-08-14	Platelet adp receptor inhibitors
NO20072286L (no)	2007-05-02	Hemming av HCV NS3-NS4A-protease
BR0212252A (pt)	2004-09-14	Métodos para reduzir a hipertensão e a insuficiência cardìaca em um mamìfero
MXPA04012965A (es)	2005-05-16	Inhibidores virales.
WO2001062272A3 (en)	2002-03-28	Soluble tumor necrosis factor receptor and il-4 inhibitor for the treatment of medical disorders
MX9605442A (es)	1997-05-31	Nuevos usos para antagonistas del factor de liberacion de corticotropina.
DK0950057T3 (da)	2003-03-10	3-pyridylenantiomerer og deres anvendelse som analgetika
NO20053111L (no)	2005-08-24	Peptider som inhiberer angiogenese, cellemigrering, celleinvasjon og celleproliferering.
EP0981352A4 (en)	2007-04-25	APLIDINE AS AN AGENT PROMOTING THE L-TYPE CALCIUM CHANNEL
HUP9801593A2 (hu)	1999-01-28	Benazeprilt vagy benazeprilátot és valzartánt tartalmazó kombinált gyógyszerkészítmények és azok alkalmazása
SG156681A1 (en)	2009-11-26	Use of ranolazine in combination with at least one remodeling agent for reversing left ventricular remodeling in the treatment of heart failure
MXPA02000330A (es)	2004-05-21	Pirrolidinas y piperidinas neurotroficas y composiciones y metodos relacionados.
NO20002408L (no)	2000-07-12	5-HT1F antagonister
ATE305311T1 (de)	2005-10-15	Zusammensetzung zur behandlung von herzinsuffizienz